microRNA-based predictor for diagnosis of frontotemporal dementia.

Iddo MagenNancy-Sarah YacovzadaJason D WarrenCarolin HellerImogen SwiftYoana BobevaAndrea MalaspinaJonathan Daniel RohrerPietro FrattaEran Hornstein

Published in: Neuropathology and applied neurobiology (2023)

The fascinating potential of diagnostic miRNA biomarkers might enable early-stage detection and a cost-effective screening approach for clinical trials that can facilitate drug development.

Keyphrases

early stage
clinical trial
loop mediated isothermal amplification
sentinel lymph node
label free
human health
open label
radiation therapy
neoadjuvant chemotherapy